Literature DB >> 15864743

Protein remodeling of the heart ventricles in hereditary hypertriglyceridemic rat: effect of ACE-inhibition.

Fedor Simko1, Václav Pelouch, Jozef Torok, Ivan Luptak, Jana Matuskova, Olga Pechanova, Pavel Babal.   

Abstract

The aim of this study was to determine whether protein remodeling of the heart ventricles and remodeling of the aorta were present in hereditary hypertriglyceridemic (hHTG) rats and whether treatment with the angiotensin-converting enzyme inhibitor, captopril could prevent these alterations. Three groups of rats were investigated in a four week experiment control Wistar /C/rats, hHTg rats, hHTg rats given captopril (100 mg/kg/day) (hHTg + CAP). In the hHTg group, the increased systolic blood pressure (SBP) was associated with hypertrophy of the LV and RV. Protein profile analysis revealed an enhancement of metabolic protein concentration in both ventricles. The concentration of total collagenous proteins was not changed in either ventricles. However, alterations in composition of cardiac collagen were detected, characterized by higher concentration of hydroxyproline in pepsin-insoluble fraction and lower concentration of hydroxyproline in pepsin soluble faction in the LV. Hypertrophy of aorta, associated with the reduction of nitric oxide dependent relaxation, was also present in hHTG rats. Captopril normalized SBP, reduced left ventricular hypertrophy (LVH), diminished metabolic protein concentration in both ventricles, and improved NO-dependent relaxation of the aorta. Furthermore, captopril partially reversed alterations in hydroxyproline concentration in soluble and insoluble collagenous fractions of the LV. We conclude that hypertrophy of both ventricles and the aorta are present in hHTG rats, along with protein remodeling of both ventricles. Captopril partially prevented left ventricular hypertrophy development and protein remodeling of the myocardium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15864743     DOI: 10.1007/s11373-004-8173-9

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  5 in total

1.  [P4HA2 promotes occurrence and progression of liver cancer by regulating the PI3K/Akt/mTOR signaling pathway].

Authors:  L Shang; W Jiang; J Zhang; W Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-05-20

2.  The effect of chronic nitric oxide synthases inhibition on regulatory proteins in rat hearts.

Authors:  Anna Spániková; Petra Simoncíková; Tána Ravingerová; Olga Pechánová; Miroslav Barancík
Journal:  Mol Cell Biochem       Date:  2008-03-10       Impact factor: 3.396

3.  Hypertension and cardiovascular remodelling in rats exposed to continuous light: protection by ACE-inhibition and melatonin.

Authors:  Fedor Simko; Olga Pechanova; Kristina Repova Bednarova; Kristina Krajcirovicova; Peter Celec; Natalia Kamodyova; Stefan Zorad; Jarmila Kucharska; Anna Gvozdjakova; Michaela Adamcova; Ludovit Paulis
Journal:  Mediators Inflamm       Date:  2014-07-06       Impact factor: 4.711

4.  Aspirin targets P4HA2 through inhibiting NF-κB and LMCD1-AS1/let-7g to inhibit tumour growth and collagen deposition in hepatocellular carcinoma.

Authors:  Tianjiao Wang; Xueli Fu; Tianzhi Jin; Lu Zhang; Bowen Liu; Yue Wu; Feifei Xu; Xue Wang; Kai Ye; Weiying Zhang; Lihong Ye
Journal:  EBioMedicine       Date:  2019-07-02       Impact factor: 8.143

5.  The Vasoactive Role of Perivascular Adipose Tissue and the Sulfide Signaling Pathway in a Nonobese Model of Metabolic Syndrome.

Authors:  Sona Cacanyiova; Samuel Golas; Anna Zemancikova; Miroslava Majzunova; Martina Cebova; Hana Malinska; Martina Hüttl; Irena Markova; Andrea Berenyiova
Journal:  Biomolecules       Date:  2021-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.